Second-line chemotherapy in patients with small-cell lung cancer: Phase II trial of ZD0473

被引：0
|
作者：
Schiller, J [1 ]
Bonomi, G [1 ]
Modiano, M [1 ]
Bonomi, P [1 ]
Cornett, P [1 ]
Kelly, K [1 ]
Koehler, M [1 ]
机构：
[1] Univ Wisconsin, Ctr Comprehens Canc, Madison, WI 53706 USA
来源：
LUNG CANCER: CURRENT TOPICS | 2001年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ZD0473 is a new generation platinum drug designed to deliver an extended spectrum of antitumour activity and overcome platinum resistance mechanisms. We present interim results from a Phase II trial of ZD0473 in patients with small-cell lung cancer (SCLC).
引用
收藏
页码：335 / 339
页数：5
相关论文
共 50 条
  • [41] Efficacy of second-line chemotherapy in poor-risk patients with refractory-relapsed small-cell lung cancer
    Wakuda, Kazushige
    Kobayashi, Haruki
    Omori, Shota
    Nakashima, Kazuhisa
    Ono, Akira
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Nakajima, Takashi
    Takahashi, Toshiaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (09) : 822 - 826
  • [42] Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: A multi-institutional retrospective analysis
    Garassino, Marina Chiara
    Torri, Valter
    Michetti, Giovanni
    Lo Dico, Monica
    La Verde, Nicla
    Aglione, Stefania
    Mancuso, Andrea
    Gallerani, Elisa
    Galetta, Domenico
    Martelli, Olga
    Collova, Elena
    Fatigoni, Sonia
    Ghidini, Antonio
    Saggia, Chiara
    Bareggi, Claudia
    Rossi, Antonio
    Farina, Gabriella
    Thatcher, Nicholas
    Blackhall, Fiona
    Lorigan, Paul
    Califano, Raffaele
    LUNG CANCER, 2011, 72 (03) : 378 - 383
  • [43] Outcomes of second-line chemotherapy in patients with relapsed extensive small cell lung cancer
    Froeschl, Sandra
    Nicholas, Garth
    Gallant, Victor
    Laurie, Scott A.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (02) : 163 - 169
  • [44] Second-line chemotherapy for non-small cell lung cancer
    Ruckdeschel, JC
    CHEST, 2006, 129 (04) : 840 - 842
  • [45] Second-line chemotherapy for non-small cell lung cancer
    De Marinis, F.
    De Santis, S.
    De Petris, L.
    ANNALS OF ONCOLOGY, 2006, 17 : V68 - V71
  • [46] Second-line chemotherapy and its evaluation in small cell lung cancer
    Huisman, C
    Postmus, PE
    Giaccone, G
    Smit, EF
    CANCER TREATMENT REVIEWS, 1999, 25 (04) : 199 - 206
  • [47] Gemcitabine as second-line treatment for advanced non-small-cell lung cancer:: A phase II trial
    Crinò, L
    Mosconi, AM
    Scagliotti, G
    Selvaggi, G
    Novello, S
    Rinaldi, M
    Della Giulia, M
    Gridelli, C
    Rossi, A
    Calandri, C
    De Marinis, F
    Noseda, M
    Tonato, M
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 2081 - 2085
  • [48] Epirubicin plus Paclitaxel Regimen as Second-line Treatment of Patients with Small-cell Lung Cancer
    Pasello, Giulia
    Carli, Paolo
    Canova, Fabio
    Bonanno, Laura
    Polo, Valentina
    Zago, Giulia
    Urso, Loredana
    Conte, Pierfranco
    Favaretto, Adolfo
    ANTICANCER RESEARCH, 2015, 35 (04) : 2183 - 2189
  • [49] Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331
    Spigel, D. R.
    Vicente, D.
    Ciuleanu, T. E.
    Gettinger, S.
    Peters, S.
    Horn, L.
    Audigier-Valette, C.
    Pardo Aranda, N.
    Juan-Vidal, O.
    Cheng, Y.
    Zhang, H.
    Shi, M.
    Luft, A.
    Wolf, J.
    Antonia, S.
    Nakagawa, K.
    Fairchild, J.
    Baudelet, C.
    Pandya, D.
    Doshi, P.
    Chang, H.
    Reck, M.
    ANNALS OF ONCOLOGY, 2021, 32 (05) : 631 - 641
  • [50] SYSTEMATIC LITERATURE REVIEW OF SECOND-LINE TREATMENTS FOR SMALL-CELL LUNG CANCER
    Hanvesakul, R.
    Rengarajan, B.
    Stack, C.
    Wilson, F.
    Adeyemi, A.
    VALUE IN HEALTH, 2022, 25 (01) : S37 - S38
12345